HCA Healthcare, Inc. $HCA Holdings Trimmed by Janus Henderson Group PLC

Janus Henderson Group PLC trimmed its holdings in HCA Healthcare, Inc. (NYSE:HCA) by 6.6% in the first quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The fund owned 1,017,441 shares of the company’s stock after selling 72,449 shares during the quarter. Janus Henderson Group PLC’s holdings in HCA Healthcare were worth $481,487,000 as of its most recent filing with the Securities and Exchange Commission.

Several other hedge funds have also recently added to or reduced their stakes in the business. Nomura Asset Management Co. Ltd. increased its stake in HCA Healthcare by 6.2% in the 4th quarter. Nomura Asset Management Co. Ltd. now owns 64,237 shares of the company’s stock worth $29,990,000 after purchasing an additional 3,724 shares in the last quarter. Advisors Capital Management LLC boosted its holdings in shares of HCA Healthcare by 61.5% in the fourth quarter. Advisors Capital Management LLC now owns 6,836 shares of the company’s stock worth $3,192,000 after buying an additional 2,604 shares during the period. Arrowstreet Capital Limited Partnership raised its holdings in shares of HCA Healthcare by 11.9% during the fourth quarter. Arrowstreet Capital Limited Partnership now owns 2,311,112 shares of the company’s stock valued at $1,078,966,000 after acquiring an additional 245,887 shares during the period. Liberty Wealth Management LLC acquired a new position in HCA Healthcare in the 4th quarter worth approximately $1,905,000. Finally, Intech Investment Management LLC raised its stake in HCA Healthcare by 10.0% during the 4th quarter. Intech Investment Management LLC now owns 55,273 shares of the company’s stock valued at $25,805,000 after purchasing an additional 5,019 shares during the period. Institutional investors and hedge funds own 62.73% of the company’s stock.

Analyst Upgrades and Downgrades

Several analysts have recently commented on the company. KeyCorp decreased their target price on HCA Healthcare from $475.00 to $435.00 and set an “overweight” rating for the company in a research report on Monday. Oppenheimer decreased their price objective on HCA Healthcare from $520.00 to $485.00 and set an “outperform” rating for the company in a research report on Monday. Stephens dropped their target price on HCA Healthcare from $560.00 to $530.00 and set an “overweight” rating on the stock in a report on Monday, April 27th. Royal Bank Of Canada restated an “outperform” rating and set a $435.00 price target on shares of HCA Healthcare in a report on Monday. Finally, Wall Street Zen downgraded shares of HCA Healthcare from a “buy” rating to a “hold” rating in a research report on Saturday, May 2nd. Fourteen analysts have rated the stock with a Buy rating, eight have issued a Hold rating and one has assigned a Sell rating to the company’s stock. According to MarketBeat.com, HCA Healthcare has an average rating of “Moderate Buy” and a consensus target price of $465.05.

HCA Healthcare Price Performance

HCA opened at $408.39 on Thursday. The company has a market capitalization of $90.60 billion, a PE ratio of 13.67, a price-to-earnings-growth ratio of 1.46 and a beta of 1.12. The business has a 50-day moving average of $386.80 and a 200-day moving average of $452.03. HCA Healthcare, Inc. has a fifty-two week low of $342.71 and a fifty-two week high of $556.52.

HCA Healthcare (NYSE:HCA) last released its quarterly earnings data on Friday, July 24th. The company reported $7.59 EPS for the quarter, topping analysts’ consensus estimates of $7.56 by $0.03. The firm had revenue of $20.23 billion for the quarter, compared to the consensus estimate of $19.76 billion. HCA Healthcare had a negative return on equity of 244.79% and a net margin of 8.77%.The firm’s revenue was up 8.7% on a year-over-year basis. During the same quarter in the prior year, the company posted $6.84 earnings per share. On average, equities research analysts expect that HCA Healthcare, Inc. will post 29.38 earnings per share for the current fiscal year.

HCA Healthcare Dividend Announcement

The firm also recently disclosed a quarterly dividend, which will be paid on Wednesday, September 30th. Investors of record on Wednesday, September 16th will be issued a $0.78 dividend. The ex-dividend date is Wednesday, September 16th. This represents a $3.12 dividend on an annualized basis and a yield of 0.8%. HCA Healthcare’s dividend payout ratio is currently 10.45%.

More HCA Healthcare News

Here are the key news stories impacting HCA Healthcare this week:

• Positive Sentiment: HCA’s stock outperformed peers during a broadly strong trading session, suggesting some investor support despite recent concerns. HCA stock outperforms competitors
• Positive Sentiment: RBC reiterated its “Outperform” rating, while Mizuho maintained an “Outperform” view and set a $475 price target, implying substantial upside from the recent trading level. RBC reiterates Outperform Mizuho price target
• Positive Sentiment: HCA appointed experienced executives to lead two Tampa hospitals, including a former Oak Hill Hospital executive, and named Jordan Fulkerson chief financial officer of HCA Florida Memorial Hospital. The moves may support local operating continuity. Tampa hospital leadership appointments Memorial Hospital CFO appointment
• Neutral Sentiment: KeyCorp, Truist, and Baird lowered or tempered their HCA price expectations, although the changes reflect analyst caution rather than a broad withdrawal of coverage. KeyCorp set a $435 target, while RBC remained positive. KeyCorp lowers price target Baird forecast Truist price outlook
• Negative Sentiment: A judge rejected a key HCA argument concerning its obligations to provide services at Mission Hospital. Separately, Dogwood Health Trust reported potential noncompliance with the contract governing HCA’s Mission Health acquisition. These developments raise the risk of additional costs, enforcement actions, or operating restrictions. Mission Hospital court ruling Mission contract compliance concerns
• Negative Sentiment: Pomerantz announced an investigation into potential investor claims involving HCA, adding legal overhang and possible reputational risk, although the announcement does not establish wrongdoing. Pomerantz investor investigation

About HCA Healthcare

HCA Healthcare is a for‑profit operator of healthcare facilities headquartered in Nashville, Tennessee. Founded in 1968, the company owns and operates a network of hospitals and related healthcare facilities and has grown through organic expansion and acquisitions to become a large provider of inpatient and outpatient services.

The company’s core activities include the operation of acute care hospitals, freestanding surgical and emergency centers, and outpatient clinics. HCA’s services encompass inpatient care, surgical services, emergency medicine, diagnostic imaging and laboratory testing, and various outpatient and ambulatory care offerings.